Browse
Submit Data
Databases
API
Help

Dataset Information

19 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Increasing the Accuracy of Single Sequence Prediction Methods Using a Deep Semi-Supervised Learning Framework.

ABSTRACT:

Motivation

Over the past 50 years, our ability to model protein sequences with evolutionary information has progressed in leaps and bounds. However, even with the latest deep learning methods, the modelling of a critically important class of proteins, single orphan sequences, remains unsolved.

Results

By taking a bioinformatics approach to semi-supervised machine learning, we develop Profile Augmentation of Single Sequences (PASS), a simple but powerful framework for building accurate single-sequence methods. To demonstrate the effectiveness of PASS we apply it to the mature field of secondary structure prediction. In doing so we develop S4PRED, the successor to the open-source PSIPRED-Single method, which achieves an unprecedented Q3 score of 75.3% on the standard CB513 test. PASS provides a blueprint for the development of a new generation of predictive methods, advancing our ability to model individual protein sequences.

Availability

The S4PRED model is available as open source software on the PSIPRED GitHub repository (https://github.com/psipred/s4pred), along with documentation. It will also be provided as a part of the PSIPRED web service (http://bioinf.cs.ucl.ac.uk/psipred/).

Supplementary information

Supplementary data are available at Bioinformatics online.

SUBMITTER: Moffat L

PROVIDER: S-EPMC8570780 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Similar Datasets

Solo: doublet identification via semi-supervised deep learning

Project description:We developed a semi-supervised deep learning framework for the identification of doublets in scRNA-seq analysis called Solo. To validate our method, we used MULTI-seq, cholesterol modified oligos (CMOs), to experimentally identify doublets in a solid tissue with diverse cell types, mouse kidney, and showed Solo recapitulated experimentally identified doublets.

2019-11-13 | GSE140262 | GEO

Genome-wide prediction of cis-regulatory regions using supervised deep learning methods.

Project description:BACKGROUND:In the human genome, 98% of DNA sequences are non-protein-coding regions that were previously disregarded as junk DNA. In fact, non-coding regions host a variety of cis-regulatory regions which precisely control the expression of genes. Thus, Identifying active cis-regulatory regions in the human genome is critical for understanding gene regulation and assessing the impact of genetic variation on phenotype. The developments of high-throughput sequencing and machine learning technologies make it possible to predict cis-regulatory regions genome wide. RESULTS:Based on rich data resources such as the Encyclopedia of DNA Elements (ENCODE) and the Functional Annotation of the Mammalian Genome (FANTOM) projects, we introduce DECRES based on supervised deep learning approaches for the identification of enhancer and promoter regions in the human genome. Due to their ability to discover patterns in large and complex data, the introduction of deep learning methods enables a significant advance in our knowledge of the genomic locations of cis-regulatory regions. Using models for well-characterized cell lines, we identify key experimental features that contribute to the predictive performance. Applying DECRES, we delineate locations of 300,000 candidate enhancers genome wide (6.8% of the genome, of which 40,000 are supported by bidirectional transcription data), and 26,000 candidate promoters (0.6% of the genome). CONCLUSION:The predicted annotations of cis-regulatory regions will provide broad utility for genome interpretation from functional genomics to clinical applications. The DECRES model demonstrates potentials of deep learning technologies when combined with high-throughput sequencing data, and inspires the development of other advanced neural network models for further improvement of genome annotations.

| S-EPMC5984344 | biostudies-literature

Solo: doublet identification via semi-supervised deep learning

Project description:Solo: doublet identification via semi-supervised deep learning

| PRJNA589061 | ENA

Deep echocardiography: data-efficient supervised and semi-supervised deep learning towards automated diagnosis of cardiac disease.

Project description:Deep learning and computer vision algorithms can deliver highly accurate and automated interpretation of medical imaging to augment and assist clinicians. However, medical imaging presents uniquely pertinent obstacles such as a lack of accessible data or a high-cost of annotation. To address this, we developed data-efficient deep learning classifiers for prediction tasks in cardiology. Using pipeline supervised models to focus relevant structures, we achieve an accuracy of 94.4% for 15-view still-image echocardiographic view classification and 91.2% accuracy for binary left ventricular hypertrophy classification. We then develop semi-supervised generative adversarial network models that can learn from both labeled and unlabeled data in a generalizable fashion. We achieve greater than 80% accuracy in view classification with only 4% of labeled data used in solely supervised techniques and achieve 92.3% accuracy for left ventricular hypertrophy classification. In exploring trade-offs between model type, resolution, data resources, and performance, we present a comprehensive analysis and improvements of efficient deep learning solutions for medical imaging assessment especially in cardiology.

| S-EPMC6550282 | biostudies-literature

Genome-wide sequence-based prediction of peripheral proteins using a novel semi-supervised learning technique.

Project description:In supervised learning, traditional approaches to building a classifier use two sets of examples with pre-defined classes along with a learning algorithm. The main limitation of this approach is that examples from both classes are required which might be infeasible in certain cases, especially those dealing with biological data. Such is the case for membrane-binding peripheral domains that play important roles in many biological processes, including cell signaling and membrane trafficking by reversibly binding to membranes. For these domains, a well-defined positive set is available with domains known to bind membrane along with a large unlabeled set of domains whose membrane binding affinities have not been measured. The aforementioned limitation can be addressed by a special class of semi-supervised machine learning called positive-unlabeled (PU) learning that uses a positive set with a large unlabeled set. METHODS In this study, we implement the first application of PU-learning to a protein function prediction problem: identification of peripheral domains. PU-learning starts by identifying reliable negative (RN) examples iteratively from the unlabeled set until convergence and builds a classifier using the positive and the final RN set. A data set of 232 positive cases and ~3750 unlabeled ones were used to construct and validate the protocol.Holdout evaluation of the protocol on a left-out positive set showed that the accuracy of prediction reached up to 95% during two independent implementations.These results suggest that our protocol can be used for predicting membrane-binding properties of a wide variety of modular domains. Protocols like the one presented here become particularly useful in the case of availability of information from one class only.

| S-EPMC3009533 | biostudies-literature

Developing Sustainable Classification of Diseases via Deep Learning and Semi-Supervised Learning.

Project description:Disease classification based on machine learning has become a crucial research topic in the fields of genetics and molecular biology. Generally, disease classification involves a supervised learning style; i.e., it requires a large number of labelled samples to achieve good classification performance. However, in the majority of the cases, labelled samples are hard to obtain, so the amount of training data are limited. However, many unclassified (unlabelled) sequences have been deposited in public databases, which may help the training procedure. This method is called semi-supervised learning and is very useful in many applications. Self-training can be implemented using high- to low-confidence samples to prevent noisy samples from affecting the robustness of semi-supervised learning in the training process. The deep forest method with the hyperparameter settings used in this paper can achieve excellent performance. Therefore, in this work, we propose a novel combined deep learning model and semi-supervised learning with self-training approach to improve the performance in disease classification, which utilizes unlabelled samples to update a mechanism designed to increase the number of high-confidence pseudo-labelled samples. The experimental results show that our proposed model can achieve good performance in disease classification and disease-causing gene identification.

| S-EPMC7551840 | biostudies-literature

A semi-supervised learning framework for quantitative structure-activity regression modelling.

Project description:MotivationQuantitative structure-activity relationship (QSAR) methods are increasingly used in assisting the process of preclinical, small molecule drug discovery. Regression models are trained on data consisting of a finite-dimensional representation of molecular structures and their corresponding target-specific activities. These supervised learning models can then be used to predict the activity of previously unmeasured novel compounds.ResultsThis work provides methods that solve three problems in QSAR modelling: (i) a method for comparing the information content between finite-dimensional representations of molecular structures (fingerprints) with respect to the target of interest, (ii) a method that quantifies how the accuracy of the model prediction degrades as a function of the distance between the testing and training data and (iii) a method to adjust for screening dependent selection bias inherent in many training datasets. For example, in the most extreme cases, only compounds which pass an activity-dependent screening threshold are reported. A semi-supervised learning framework combines (ii) and (iii) and can make predictions, which take into account the similarity of the testing compounds to those in the training data and adjust for the reporting selection bias. We illustrate the three methods using publicly available structure-activity data for a large set of compounds reported by GlaxoSmithKline (the Tres Cantos AntiMalarial Set, TCAMS) to inhibit asexual in vitro Plasmodium falciparum growth.Availabilityand implementationhttps://github.com/owatson/PenalizedPrediction.Supplementary informationSupplementary data are available at Bioinformatics online.

| S-EPMC8058768 | biostudies-literature

DeepSol: a deep learning framework for sequence-based protein solubility prediction.

Project description:MotivationProtein solubility plays a vital role in pharmaceutical research and production yield. For a given protein, the extent of its solubility can represent the quality of its function, and is ultimately defined by its sequence. Thus, it is imperative to develop novel, highly accurate in silico sequence-based protein solubility predictors. In this work we propose, DeepSol, a novel Deep Learning-based protein solubility predictor. The backbone of our framework is a convolutional neural network that exploits k-mer structure and additional sequence and structural features extracted from the protein sequence.ResultsDeepSol outperformed all known sequence-based state-of-the-art solubility prediction methods and attained an accuracy of 0.77 and Matthew's correlation coefficient of 0.55. The superior prediction accuracy of DeepSol allows to screen for sequences with enhanced production capacity and can more reliably predict solubility of novel proteins.Availability and implementationDeepSol's best performing models and results are publicly deposited at https://doi.org/10.5281/zenodo.1162886 (Khurana and Mall, 2018).Supplementary informationSupplementary data are available at Bioinformatics online.

| S-EPMC6355112 | biostudies-literature

Neuroanatomical heterogeneity of schizophrenia revealed by semi-supervised machine learning methods.

Project description:Schizophrenia is associated with heterogeneous clinical symptoms and neuroanatomical alterations. In this work, we aim to disentangle the patterns of neuroanatomical alterations underlying a heterogeneous population of patients using a semi-supervised clustering method. We apply this strategy to a cohort of patients with schizophrenia of varying extends of disease duration, and we describe the neuroanatomical, demographic and clinical characteristics of the subtypes discovered. METHODS:We analyze the neuroanatomical heterogeneity of 157 patients diagnosed with Schizophrenia, relative to a control population of 169 subjects, using a machine learning method called CHIMERA. CHIMERA clusters the differences between patients and a demographically-matched population of healthy subjects, rather than clustering patients themselves, thereby specifically assessing disease-related neuroanatomical alterations. Voxel-Based Morphometry was conducted to visualize the neuroanatomical patterns associated with each group. The clinical presentation and the demographics of the groups were then investigated. RESULTS:Three subgroups were identified. The first two differed substantially, in that one involved predominantly temporal-thalamic-peri-Sylvian regions, whereas the other involved predominantly frontal regions and the thalamus. Both subtypes included primarily male patients. The third pattern was a mix of these two and presented milder neuroanatomic alterations and comprised a comparable number of men and women. VBM and statistical analyses suggest that these groups could correspond to different neuroanatomical dimensions of schizophrenia. CONCLUSION:Our analysis suggests that schizophrenia presents distinct neuroanatomical variants. This variability points to the need for a dimensional neuroanatomical approach using data-driven, mathematically principled multivariate pattern analysis methods, and should be taken into account in clinical studies.

| S-EPMC6013334 | biostudies-literature

Semi-supervised learning improves gene expression-based prediction of cancer recurrence.

Project description:Gene expression profiling has shown great potential in outcome prediction for different types of cancers. Nevertheless, small sample size remains a bottleneck in obtaining robust and accurate classifiers. Traditional supervised learning techniques can only work with labeled data. Consequently, a large number of microarray data that do not have sufficient follow-up information are disregarded. To fully leverage all of the precious data in public databases, we turned to a semi-supervised learning technique, low density separation (LDS).Using a clinically important question of predicting recurrence risk in colorectal cancer patients, we demonstrated that (i) semi-supervised classification improved prediction accuracy as compared with the state of the art supervised method SVM, (ii) performance gain increased with the number of unlabeled samples, (iii) unlabeled data from different institutes could be employed after appropriate processing and (iv) the LDS method is robust with regard to the number of input features. To test the general applicability of this semi-supervised method, we further applied LDS on human breast cancer datasets and also observed superior performance. Our results demonstrated great potential of semi-supervised learning in gene expression-based outcome prediction for cancer patients.bing.zhang@vanderbilt.edu.Supplementary data are available at Bioinformatics online.

| S-EPMC3198572 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data